Patents for C12R 1 - Micro-organisms (92,025)
02/1998
02/10/1998US5716620 Vaccines, diagnostic immunoassay
02/10/1998US5716617 Concurrent purification of mixture
02/05/1998WO1998004736A1 Mutant urease and method of use for determination of urea
02/05/1998WO1998004733A1 Production of amino acids and enzymes used therefor
02/05/1998WO1998004726A1 Hsv strain lacking functional icp27 and icp34.5 genes
02/05/1998WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
02/05/1998WO1998004715A1 Novel strains of escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production
02/05/1998WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection
02/05/1998WO1998004691A1 Human proteolipid
02/05/1998WO1998004685A1 Hppd gene and inhibitors
02/05/1998WO1998004678A2 Micro-organism which can desulphurise benzothiophenes
02/05/1998WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
02/05/1998WO1998004300A1 Use of microorganisms for processing bioprosthetic tissue
02/05/1998WO1998004286A2 Assembly-deficient herpesvirus vaccine
02/05/1998WO1997047744A3 T-cell selective interleukin-4 agonists
02/05/1998WO1997040069A3 Secreted proteins and polynucleotides encoding them
02/05/1998WO1997039623A3 Improved production of insecticidal proteins
02/05/1998CA2262016A1 Production of amino acids and enzymes used therefor
02/05/1998CA2262002A1 Hppd gene and inhibitors
02/05/1998CA2261563A1 Human proteolipid
02/05/1998CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof
02/05/1998CA2261071A1 Assembly-deficient herpesvirus vaccine
02/04/1998EP0822259A1 Process for the production of delta-decalactone
02/04/1998EP0822258A2 Vector for positive selection, based on the cap gene, the pCAPs vector and its applications
02/04/1998EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy
02/04/1998EP0822253A2 Novel microbial strain, method for biodegrading organic compounds and method for environmental remediation
02/04/1998EP0822252A2 Microbial strains, method for biodegrading organic compounds and method for environmental remediation
02/04/1998EP0821982A2 High-Temperature Desulfurization by Microorganisms
02/04/1998EP0821968A2 Antihypertensive agent and method for preparing same
02/04/1998EP0821742A1 Phycobilisomes, derivatives, and uses therefor
02/04/1998EP0821739A1 An adenovirus helper-virus system
02/04/1998EP0821738A2 Repertoire cloning process, products derived therefrom and uses for said products
02/04/1998EP0821737A1 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF
02/04/1998EP0821736A1 Bacteriocins
02/04/1998EP0821735A1 Helicobacter pylori cagi region
02/04/1998EP0821732A1 Altered polypeptides with increased half-life
02/04/1998EP0821729A1 Structure-based designed herbicide resistant products
02/04/1998EP0821728A1 Tie-2 ligands, methods of making and uses thereof
02/04/1998EP0821698A1 Protective helicobacter antigens
02/04/1998EP0760848B1 Lactobacillus strains of human origin, their compositions and uses thereof
02/04/1998EP0694044A4 Method and product for regulating cell responsiveness to external signals
02/04/1998EP0652967B1 Self-assembling replication defective hybrid virus particles
02/04/1998EP0651800B1 Basophil granule proteins
02/04/1998EP0568537B1 Genetic modification of endothelial cells
02/04/1998EP0460072B1 Human elastase inhibitor
02/04/1998EP0383837B1 Alveolar surfactant proteins
02/04/1998CN1172511A Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
02/04/1998CN1172501A Method for disigning alpha-amylase mutants with predetermined properties
02/04/1998CN1172500A Amylase variants
02/04/1998CN1172498A Detergent compositions containing lipase and protease
02/04/1998CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell
02/04/1998CN1172165A Fermentative production of d- biotin
02/04/1998CN1172161A Akaweiki transferase and its preparation and use
02/03/1998US5714642 Resolution of immixtures of stereoisomeric alcohols
02/03/1998US5714595 Mechanism-based screen for retinoid X receptor agonists and antagonists
02/03/1998US5714593 Vaccines, medical diagnosis
02/03/1998US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence
02/03/1998US5714377 Modified fungal cells and method for producing recombinant products
02/03/1998US5714376 For products with specific anticoagulant activity
02/03/1998US5714371 Method for refolding insoluble aggregates of hepatitis C virus protease
02/03/1998US5714364 Phenylalanine dehydrogenase production
02/03/1998US5714363 Polypeptide synthetase having the catalytic hydrolysis activity, changing 3-exomethylenecephalosporin c to deacetylcephalosporin c
02/03/1998US5714359 Apparatus and method for electrostatic endothelial cell seeding in a vascular prosthesis
02/03/1998US5714357 Biosynthesis comprising a microorganism of the genus rhodococcus, alcaligenes, pseudomonas or brevibacterium capable of asymmetrically hydrolyzing a nitrile group of a racemic alpha-hydroxynitrile
02/03/1998US5714355 Biologically pure culture of mutant microorganism
02/03/1998US5714353 Safe vectors for gene therapy
02/03/1998US5714352 Genetic engineering
02/03/1998US5714348 Culturing, supplying glycerol to inoculated fermentation broth at a rate proportional to oxygen uptake rate of microorganism until a threshold value is reached, then providing glycerol to broth at constant supply until finish
02/03/1998US5714334 Gene and method for production of an IgA binding protein
02/03/1998US5714314 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method
02/03/1998US5714183 Purification
02/03/1998US5714166 Bioactive and/or targeted dendrimer conjugates
02/03/1998US5714152 Herpes simplex virus VP16 vaccines
02/03/1998CA1339654C Gene therapy using gene fusion for genetic or acquired disorders
01/1998
01/29/1998WO1998003873A1 Treatment and diagnosis of cancer
01/29/1998WO1998003681A1 PROBES FOR DETECTING AND IDENTIFYING $i(HELICOBACTER PYLORI)
01/29/1998WO1998003671A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid
01/29/1998WO1998003666A1 Recombinant vectors
01/29/1998WO1998003639A1 PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY
01/29/1998WO1998003635A1 Regions nonessential for the proliferation of avipoxviruses, and recombinant avipoxviruses and vaccines prepared with the use of the same
01/29/1998WO1998003627A1 Process for the preparation of malted cereals
01/29/1998WO1998003551A1 Cd6 ligand
01/29/1998WO1998003539A1 G-protein coupled receptor hnfds78
01/29/1998WO1998003480A1 PROCESS FOR THE RECOVERY OF CRYSTALLINE β-CAROTENE FROM A NATURAL SOURCE
01/29/1998DE19628454A1 New rhamno-lipid-alginate polymer complexes
01/29/1998CA2259958A1 Protein engineering of glucoamylase to increase ph optimum, substrate specificity and thermostability
01/29/1998CA2232142A1 Cd6 ligand
01/28/1998EP0821068A2 Novel sphingolipids and a process thereto
01/28/1998EP0821066A1 Polypeptide of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptide
01/28/1998EP0821065A2 Farnesyl diphosphate synthase
01/28/1998EP0821064A2 Recombinant fructosyl amino acid oxidase
01/28/1998EP0821063A2 Improved riboflavin production
01/28/1998EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44)
01/28/1998EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations
01/28/1998EP0821057A1 Baker's yeast
01/28/1998EP0820590A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals
01/28/1998EP0820517A1 S-adenosyl-l-homocystein hydrolyse promoter
01/28/1998EP0820509A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
01/28/1998EP0820507A1 Ndf peptides
01/28/1998EP0820471A1 Antibodies against heart muscle actin